Cochrane Abstracts
Regular treatment with salmeterol for chronic asthma: serious adverse events: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Regular Treatment With Salmeterol for Chronic Asthma: Serious Adverse Events: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436203/all/N_acetylcysteine_for_sepsis_and_systemic_inflammatory_response_in_adults:_Cochrane_systematic_review. Accessed 26 September 2023.
Regular treatment with salmeterol for chronic asthma: serious adverse events: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436203/all/N_acetylcysteine_for_sepsis_and_systemic_inflammatory_response_in_adults:_Cochrane_systematic_review. Accessed September 26, 2023.
Regular treatment with salmeterol for chronic asthma: serious adverse events: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/436203/all/N_acetylcysteine_for_sepsis_and_systemic_inflammatory_response_in_adults:_Cochrane_systematic_review
Regular Treatment With Salmeterol for Chronic Asthma: Serious Adverse Events: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2023 September 26]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436203/all/N_acetylcysteine_for_sepsis_and_systemic_inflammatory_response_in_adults:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Regular treatment with salmeterol for chronic asthma: serious adverse events: Cochrane systematic review
ID - 436203
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436203/all/N_acetylcysteine_for_sepsis_and_systemic_inflammatory_response_in_adults:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -
